-
-
公开(公告)号:EP3909985A1
公开(公告)日:2021-11-17
申请号:EP21167818.0
申请日:2017-06-27
申请人: MorphoSys AG
IPC分类号: C07K16/28 , A61K39/395 , A61P35/00
摘要: The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
-
公开(公告)号:EP3903821A1
公开(公告)日:2021-11-03
申请号:EP21165598.0
申请日:2017-10-27
申请人: MorphoSys AG
IPC分类号: A61K39/395 , A61K31/00 , C07K16/28 , A61P35/00
摘要: The present disclosure describes a pharmaceutical combination of an anti-CD19 antibody and a BCL-2 inhibitor for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.
-
公开(公告)号:EP3893841A1
公开(公告)日:2021-10-20
申请号:EP19820750.8
申请日:2019-12-13
申请人: MorphoSys AG
发明人: BROCKS, Bodo , KELLERER, Robert
-
-
公开(公告)号:EP3532098A1
公开(公告)日:2019-09-04
申请号:EP17797564.6
申请日:2017-10-27
申请人: MorphoSys AG
IPC分类号: A61K39/395 , A61K31/00 , C07K16/28 , A61P35/00
-
7.
公开(公告)号:EP3302550B1
公开(公告)日:2019-08-28
申请号:EP16725504.1
申请日:2016-05-25
申请人: MorphoSys AG
发明人: ENDELL, Jan , BOXHAMMER, Rainer , WINDERLICH, Mark
IPC分类号: A61K39/395 , A61K31/519 , A61P35/00 , A61K31/505 , C07K16/28
-
公开(公告)号:EP3475303A1
公开(公告)日:2019-05-01
申请号:EP17735440.4
申请日:2017-06-27
申请人: MorphoSys AG
IPC分类号: C07K16/28 , A61K39/395
-
公开(公告)号:EP3423498A1
公开(公告)日:2019-01-09
申请号:EP17708766.5
申请日:2017-03-03
申请人: MorphoSys AG
发明人: HÄRTLE, Stefan
IPC分类号: C07K16/42 , G01N33/574
-
公开(公告)号:EP3359565A1
公开(公告)日:2018-08-15
申请号:EP16782018.2
申请日:2016-10-04
发明人: KRAUS, Alexandra , HARTLEPP, Felix , MAHR, Andrea , WEINSCHENK, Toni , WAGNER, Claudia , MAURER, Dominik
CPC分类号: C07K16/2833 , A61K2039/505 , C07K14/4748 , C07K16/18 , C07K2317/21 , C07K2317/32 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/565 , C07K2317/732 , G01N33/53 , G01N33/6854 , G01N2500/04
摘要: The present invention relates to antibodies or fragments thereof binding to human WT1/HLA. In particular, the present invention relates to antibodies or fragments thereof that have combined improved and/or beneficial properties, and are therefore suited for clinical development.
-
-
-
-
-
-
-
-
-